Exercise Interventions for Improving Eye Control Post Strabismus Surgery

February 7, 2023 updated by: Amany Refaat Mohamed Abdel Wahid, Cairo University

Exercise Interventions of Eye Muscles for Improving Eye Control Post Strabismus Surgery

The purpose of this study will be focused on the following issue:

1. The aim of this study is to determine therapeutic effect of postoperative eye exercises on improving eye control after the strabismus surgery.

HYPOTHESES:

It will be hypothesized that:

• Eye exercises have a positive effect on improving eye control post strabismus surgery.

RESEARCH QUESTION:"

• Do postoperative eye exercises improve eye control post strabismus surgery?

Study Overview

Detailed Description

Therapeutic procedures:

  • Patient will be informed about measurement and treatment procedure before beginning of the treatment.
  • Patient will be asked to follow physician instructions.
  • Patients will be asked to avoid participation in any rehabilitation program prior to the study which may affect the result of the study.
  • Measurement procedures will be applied for each patient.
  • They will start the treatment program after 2 weeks of the surgery.

The subjects will be divided into two groups (experimental group and control group) with equal numbers of patients in each group:

Control group Participants within the control group will receive traditional care and medication following strabismus surgery.

Experimental group Participants within the experimental group will receive physiotherapy exercises beside traditional care and medication after strabismus surgery. Physical therapy exercises will apply in the office and home. Office exercises will involve palming exercise, pencil push-ups, brock string exercise, thumb exercise (Near-distance jump), balance board exercise, Proprioceptors Neuromuscular Facilitating (PNF) exercise, occlusive therapy, eye hand coordination and computer therapy. Office exercises will be done two sessions per week for three months. Each session will be about 1 hour. Exercises will also perform at home from the first session including eye exercises in all directions, pencil push-ups, thumb exercise (Near-distance jump),brock string exercise, and dominant eye occlusion for 1 hour daily.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 15 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Criteria of selecting the patients include the following:
  • Patients are both males and females.
  • Their age will range from (5-15) years.
  • Patients received strabismus operation.
  • They will be selected from Outpatient Clinic of Research Institute of Ophthalmology.
  • Patients will begin the training program after 2 weeks of operation.
  • All types of strabismus surgery will be included.

Exclusion Criteria:

The subjects will be excluded from the study if they meet one of the following criteria;

  • Muscular disorders that will impair performance during training.
  • Any organic lesion in the eye.
  • Neurological disorders.
  • Malignant conditions.
  • Psychiatric illness, severe behavior or cognitive disorders.
  • Children who can't understand the therapist's instructions and orders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: FACTORIAL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: experimental group
experimental group will receive eye exercises in addition to medication and eye glasses post strabismus surgery
Application of eye exercise for improving eye control post strabismus surgery
Other Names:
  • experimental
medication and eye glasses used post strabismus surgery
Other Names:
  • control
ACTIVE_COMPARATOR: control group
control group will receive medication and eye glasses post strabismus surgery
medication and eye glasses used post strabismus surgery
Other Names:
  • control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changing in eye control
Time Frame: before the treatment and after 12 weeks (at the end of the treatment period )

The level of control will be evaluated in each patient at both distance and near fixation using Intermittent Exotropia Control Scale.

Fixation targets will be at 3 meters for distance fixation and it will be at 33 centimeters for near fixation.

Intermittent Exotropia Control Scale

5 = Constant exotropia 4 = Exotropia > 50% of the exam before dissociation 3 = Exotropia < 50% of the exam before dissociation 2 = No exotropia unless dissociated, recovers in > 5 seconds

1 = No exotropia unless dissociated, recovers in 1-5 seconds 0 = No exotropia unless dissociated, recovers in < 1 second (phoria)

The scale ranges from 0 (phoria, best control) to 5 (constant exotropia, worst control).

before the treatment and after 12 weeks (at the end of the treatment period )

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amany Abdel Wahid, PhD, Lecturer

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 15, 2022

Primary Completion (ACTUAL)

July 15, 2022

Study Completion (ACTUAL)

August 15, 2022

Study Registration Dates

First Submitted

February 26, 2022

First Submitted That Met QC Criteria

March 21, 2022

First Posted (ACTUAL)

March 31, 2022

Study Record Updates

Last Update Posted (ACTUAL)

February 8, 2023

Last Update Submitted That Met QC Criteria

February 7, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • P.T.REC/012/003505

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe